{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:22:15Z","timestamp":1782793335645,"version":"3.54.5"},"reference-count":193,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["4000810"],"award-info":[{"award-number":["4000810"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Cancer therapy through anticancer drugs and radiotherapy is associated with several side effects as well as tumor resistance to therapy. The genotoxic effects of chemotherapy and radiotherapy may lead to genomic instability and increased risk of second cancers. Furthermore, some responses in the tumor may induce the exhaustion of antitumor immunity and increase the resistance of cancer cells to therapy. Administration of low-toxicity adjuvants to protect normal tissues and improve therapy efficacy is an intriguing strategy. Several studies have focused on natural-derived agents for improving the antitumor efficiency of radiotherapy, chemotherapy, and novel anticancer drugs such as immunotherapy and targeted cancer therapy. Resveratrol is a naturally occurring substance with intriguing antioxidant, cardioprotective, anti-diabetes, and antitumor properties. Resveratrol has been demonstrated to modulate tumor resistance and mitigate normal tissue toxicity following exposure to various drugs and ionizing radiation. Compelling data suggest that resveratrol may be an appealing adjuvant in combination with various anticancer modalities. Although the natural form of resveratrol has some limitations, such as low absorption in the intestine and low bioavailability, several experiments have demonstrated that using certain carriers, such as nanoparticles, can increase the therapeutic efficacy of resveratrol in preclinical studies. This review highlights various effects of resveratrol that may be useful for cancer therapy. Consequently, we describe how resveratrol can protect normal tissue from genomic instability. In addition, the various mechanisms by which resveratrol exerts its antitumor effects are addressed. Moreover, the outcomes of combination therapy with resveratrol and other anticancer agents are reviewed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026623666221014152759","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T15:04:01Z","timestamp":1665759841000},"page":"629-648","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review"],"prefix":"10.2174","volume":"23","author":[{"given":"Peyman","family":"Amini","sequence":"additional","affiliation":[{"name":"Medical Technology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Moazamiyanfar","sequence":"additional","affiliation":[{"name":"Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sedigh","family":"Dakkali","sequence":"additional","affiliation":[{"name":"School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khani","sequence":"additional","affiliation":[{"name":"Department of Radiation Sciences, Alley School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Jafarzadeh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kave","family":"Mouludi","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kerman-shah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Khodamoradi","sequence":"additional","affiliation":[{"name":"Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kerman-shah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Johari","sequence":"additional","affiliation":[{"name":"Department of Technologic Radiologic, School of Allied of Medical Sciences, Ahvaz Jundishapur University, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Taeb","sequence":"additional","affiliation":[{"name":"Department of Radiology, School of Paramedical Sciences, Guilan University of Medical Sciences, Rasht, Iran"},{"name":"Medical Biotechnology Research Center, School of Para-medical Sciences, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Najafi","sequence":"additional","affiliation":[{"name":"Medical Technology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran"},{"name":"Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kerman-shah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tips.2019.01.005","volume":"40","author":"Kalimutho M.","year":"2019","unstructured":"Kalimutho M.; Nones K.; Srihari S.; Duijf P.H.G.; Waddell N.; Khanna K.K.; Patterns of genomic instability in breast cancer. Trends Pharmacol Sci 2019,40(3),198-211","journal-title":"Trends Pharmacol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","volume":"168","author":"Tubbs A.","year":"2017","unstructured":"Tubbs A.; Nussenzweig A.; Endogenous DNA damage as a source of genomic instability in cancer. Cell 2017,168(4),644-656","journal-title":"Cell"},{"key":"ref=3","first-page":"5","volume":"5","author":"Yao Y.","year":"2014","unstructured":"Yao Y.; Dai W.; Genomic instability and cancer. J Carcinog Mutagen 2014,5,5","journal-title":"J Carcinog Mutagen"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mrfmmm.2009.06.003","volume":"669","author":"Gorman S.","year":"2009","unstructured":"Gorman S.; Tosetto M.; Lyng F.; Howe O.; Sheahan K.; O\u2019Donoghue D.; Hyland J.; Mulcahy H.; O\u2019Sullivan J.; Radiation and chemotherapy bystander effects induce early genomic instability events: Telomere shortening and bridge formation coupled with mitochondrial dysfunction. Mutat Res 2009,669(1-2),131-138","journal-title":"Mutat Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(15)61167-9","volume":"386","author":"Kamiya K.","year":"2015","unstructured":"Kamiya K.; Ozasa K.; Akiba S.; Niwa O.; Kodama K.; Takamura N.; Zaharieva E.K.; Kimura Y.; Wakeford R.; Long-term effects of radiation exposure on health. Lancet 2015,386(9992),469-478","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jnci\/djj001","volume":"98","author":"Travis L.B.","year":"2006","unstructured":"Travis L.B.; Rabkin C.S.; Brown L.M.; Allan J.M.; Alter B.P.; Ambrosone C.B.; Begg C.B.; Caporaso N.; Chanock S.; DeMichele A.; Figg W.D.; Gospodarowicz M.K.; Hall E.J.; Hisada M.; Inskip P.; Kleinerman R.; Little J.B.; Malkin D.; Ng A.K.; Offit K.; Pui C.H.; Robison L.L.; Rothman N.; Shields P.G.; Strong L.; Taniguchi T.; Tucker M.A.; Greene M.H.; Cancer survivorship--genetic susceptibility and second primary cancers: Research strategies and recommendations. J Natl Cancer Inst 2006,98(1),15-25","journal-title":"J Natl Cancer Inst"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jjco\/hyi208","volume":"36","author":"Kawaguchi T.","year":"2006","unstructured":"Kawaguchi T.; Matsumura A.; Iuchi K.; Ishikawa S.; Maeda H.; Fukai S.; Komatsu H.; Kawahara M.; Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol 2006,36(1),7-11","journal-title":"Jpn J Clin Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11764-013-0278-6","volume":"7","author":"Corkum M.","year":"2013","unstructured":"Corkum M.; Hayden J.A.; Kephart G.; Urquhart R.; Schlievert C.; Porter G.; Screening for new primary cancers in cancer survivors compared to non-cancer controls: A systematic review and meta-analysis. J Cancer Surviv 2013,7(3),455-463","journal-title":"J Cancer Surviv"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"Srinivas U.S.","year":"2019","unstructured":"Srinivas U.S.; Tan B.W.Q.; Vellayappan B.A.; Jeyasekharan A.D.; ROS and the DNA damage response in cancer. Redox Biol 2019,25,101084","journal-title":"Redox Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3322\/canjclin.55.5.319","volume":"55","author":"D\u2019Andrea G.M.","year":"2005","unstructured":"D\u2019Andrea G.M.; Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005,55(5),319-321","journal-title":"CA Cancer J Clin"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1568009619666191019143539","volume":"20","author":"Mortezaee K.","year":"2020","unstructured":"Mortezaee K.; Najafi M.; Farhood B.; Ahmadi A.; Shabeeb D.; Musa A.E.; Resveratrol as an adjuvant for normal tissues protection and tumor sensitization. Curr Cancer Drug Targets 2020,20(2),130-145","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms18122589","volume":"18","author":"Ko J.H.","year":"2017","unstructured":"Ko J.H.; Sethi G.; Um J.Y.; Shanmugam M.K.; Arfuso F.; Kumar A.P.; Bishayee A.; Ahn K.S.; The role of resveratrol in cancer therapy. Int J Mol Sci 2017,18(12),2589","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/nyas.13466","volume":"1403","author":"Jiang Z.","year":"2017","unstructured":"Jiang Z.; Chen K.; Cheng L.; Yan B.; Qian W.; Cao J.; Li J.; Wu E.; Ma Q.; Yang W.; Resveratrol and cancer treatment. Updates Ann N Y Acad Sci 2017,1403(1),59-69","journal-title":"Updates Ann N Y Acad Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"105725","DOI":"10.1016\/j.phrs.2021.105725","volume":"170","author":"Parsamanesh N.","year":"2021","unstructured":"Parsamanesh N.; Asghari A.; Sardari S.; Tasbandi A.; Jamialahmadi T.; Xu S.; Sahebkar A.; Resveratrol and endothelial function: A literature review. Pharmacol Res 2021,170,105725","journal-title":"Pharmacol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/biom9060209","volume":"9","author":"Posadino A.M.","year":"2019","unstructured":"Posadino A.M.; Giordo R.; Cossu A.; Nasrallah G.K.; Shaito A.; Abou-Saleh H.; Eid A.H.; Pintus G.; Flavin oxidase-induced ros generation modulates PKC biphasic effect of resveratrol on endothelial cell survival. Biomolecules 2019,9(6),209","journal-title":"Biomolecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/antiox10020224","volume":"10","author":"Giordo R.","year":"2021","unstructured":"Giordo R.; Nasrallah G.K.; Posadino A.M.; Galimi F.; Capobianco G.; Eid A.H.; Pintus G.; Resveratrol-elicited PKC inhibition counteracts NOX-mediated endothelial to mesenchymal transition in human retinal endothelial cells exposed to high glucose. Antioxidants 2021,10(2),224","journal-title":"Antioxidants"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.3390\/molecules26216600","volume":"26","author":"Raj P.","year":"2021","unstructured":"Raj P.; Thandapilly S.J.; Wigle J.; Zieroth S.; Netticadan T.; A Comprehensive analysis of the efficacy of resveratrol in atherosclerotic cardiovascular disease, myocardial infarction and heart failure. Molecules 2021,26(21),6600","journal-title":"Molecules"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3390\/ijms21144962","volume":"21","author":"Bhagani H.","year":"2020","unstructured":"Bhagani H.; Nasser S.A.; Dakroub A.; El-Yazbi A.F.; Eid A.A.; Kobeissy F.; Pintus G.; Eid A.H.; The mitochondria: A target of polyphenols in the treatment of diabetic cardiomyopathy. Int J Mol Sci 2020,21(14),4962","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.3390\/ijms22094792","volume":"22","author":"Ros P.","year":"2021","unstructured":"Ros P.; Argente J.; Chowen J.A.; Effects of maternal resveratrol intake on the metabolic health of the offspring. Int J Mol Sci 2021,22(9),4792","journal-title":"Int J Mol Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5644171","DOI":"10.1155\/2021\/5644171","volume":"2021","author":"Zhang T.","year":"2021","unstructured":"Zhang T.; He Q.; Liu Y.; Chen Z.; Hu H.; Efficacy and safety of resveratrol supplements on blood lipid and blood glucose control in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2021,2021,5644171","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1002\/jcp.28134","volume":"234","author":"Momtazi-Borojeni A.A.","year":"2019","unstructured":"Momtazi-Borojeni A.A.; Katsiki N.; Pirro M.; Banach M.; Rasadi K.A.; Sahebkar A.; Dietary natural products as emerging lipoprotein(a)-lowering agents. J Cell Physiol 2019,234(8),12581-12594","journal-title":"J Cell Physiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"105287","DOI":"10.1016\/j.phrs.2020.105287","volume":"163","author":"Mirhadi E.","year":"2021","unstructured":"Mirhadi E.; Roufogalis B.D.; Banach M.; Barati M.; Sahebkar A.; Resveratrol: Mechanistic and therapeutic perspectives in pulmonary arterial hypertension. Pharmacol Res 2021,163,105287","journal-title":"Pharmacol Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"894305","DOI":"10.3389\/fcell.2022.894305","volume":"10","author":"Giordo R.","year":"2022","unstructured":"Giordo R.; Wehbe Z.; Posadino A.M.; Erre G.L.; Eid A.H.; Mangoni A.A.; Pintus G.; Disease-associated regulation of non-coding RNAs by resveratrol: Molecular insights and therapeutic applications. Front Cell Dev Biol 2022,10,894305","journal-title":"Front Cell Dev Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4149\/av_2020_309","volume":"64","author":"Ramdani L.H.","year":"2020","unstructured":"Ramdani L.H.; Bachari K.; Potential therapeutic effects of Resveratrol against SARS-CoV-2. Acta Virol 2020,64(3),276-280","journal-title":"Acta Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"112767","DOI":"10.1016\/j.biopha.2022.112767","volume":"148","author":"van Brummelen R.","year":"2022","unstructured":"van Brummelen R.; van Brummelen A.C.; The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 \u2013 A formulator\u2019s perspective. Biomed Pharmacother 2022,148,112767","journal-title":"Biomed Pharmacother"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2174\/138920009789375423","volume":"10","author":"Brisdelli F.","year":"2009","unstructured":"Brisdelli F.; D\u2019Andrea G.; Bozzi A.; Resveratrol: A natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 2009,10(6),530-546","journal-title":"Curr Drug Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/bph.13492","volume":"174","author":"Xia N.","year":"2017","unstructured":"Xia N.; Daiber A.; F&#xF6;rstermann U.; Li H.; Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol 2017,174(12),1633-1646","journal-title":"Br J Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1248\/cpb.30.1766","volume":"30","author":"Arichi H.","year":"1982","unstructured":"Arichi H.; Kimura Y.; Okuda H.; Baba K.; Kozawa M.; Arichi S.; Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull (Tokyo) 1982,30(5),1766-1770","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"Jang M.","year":"1997","unstructured":"Jang M.; Cai L.; Udeani G.O.; Slowing K.V.; Thomas C.F.; Beecher C.W.W.; Fong H.H.S.; Farnsworth N.R.; Kinghorn A.D.; Mehta R.G.; Moon R.C.; Pezzuto J.M.; Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997,275(5297),218-220","journal-title":"Science"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tibtech.2007.11.002","volume":"26","author":"Halls C.","year":"2008","unstructured":"Halls C.; Yu O.; Potential for metabolic engineering of resveratrol biosynthesis. Trends Biotechnol 2008,26(2),77-81","journal-title":"Trends Biotechnol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"De Ruysscher D.","year":"2019","unstructured":"De Ruysscher D.; Niedermann G.; Burnet N.G.; Siva S.; Lee A.W.; Hegi-Johnson F.; Radiotherapy toxicity. Nat Rev Dis Primers 2019,5(1),1-20","journal-title":"Nat Rev Dis Primers"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"120057","DOI":"10.1016\/j.lfs.2021.120057","volume":"286","author":"Mortezaee K.","year":"2021","unstructured":"Mortezaee K.; Majidpoor J.; The impact of hypoxia on immune state in cancer. Life Sci 2021,286,120057","journal-title":"Life Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10495-021-01689-7","volume":"26","author":"Fu X.","year":"2021","unstructured":"Fu X.; Li M.; Tang C.; Huang Z.; Najafi M.; Targeting of cancer cell death mechanisms by resveratrol: A review. Apoptosis 2021,26(11-12),561-573","journal-title":"Apoptosis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1021\/jf3001108","volume":"60","author":"Andres-Lacueva C.","year":"2012","unstructured":"Andres-Lacueva C.; Macarulla M.T.; Rotches-Ribalta M.; Boto-Ord&#xF3;&#xF1;ez M.; Urpi-Sarda M.; Rodr&#xED;guez V.M.; Portillo M.P.; Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol. J Agric Food Chem 2012,60(19),4833-4840","journal-title":"J Agric Food Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e115359","DOI":"10.1371\/journal.pone.0115359","volume":"9","author":"Murakami I.","year":"2014","unstructured":"Murakami I.; Chaleckis R.; Pluskal T.; Ito K.; Hori K.; Ebe M.; Yanagida M.; Kondoh H.; Metabolism of skin-absorbed resveratrol into its glucuronized form in mouse skin. PLoS One 2014,9(12),e115359","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4052094","DOI":"10.1155\/2017\/4052094","volume":"2017","author":"Wang S.","year":"2017","unstructured":"Wang S.; Wang Z.; Yang S.; Yin T.; Zhang Y.; Qin Y.; Weinreb R.N.; Sun X.; Tissue distribution of trans -resveratrol and its metabolites after oral administration in human eyes. J Ophthalmol 2017,2017,4052094","journal-title":"J Ophthalmol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbadis.2014.11.004","volume":"1852","author":"Singh C.K.","year":"2015","unstructured":"Singh C.K.; Ndiaye M.A.; Ahmad N.; Resveratrol and cancer: Challenges for clinical translation. Biochim Biophys Acta Mol Basis Dis 2015,1852(6),1178-1185","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jddst.2019.03.017","volume":"51","author":"Ahmadi Z.","year":"2019","unstructured":"Ahmadi Z.; Mohammadinejad R.; Ashrafizadeh M.; Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades. J Drug Deliv Sci Technol 2019,51,591-604","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/biof.1405","volume":"44","author":"Peng R.M.","year":"2018","unstructured":"Peng R.M.; Lin G.R.; Ting Y.; Hu J.Y.; Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene. Biofactors 2018,44(1),5-15","journal-title":"Biofactors"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"Ren B.","year":"2021","unstructured":"Ren B.; Kwah M.X.Y.; Liu C.; Ma Z.; Shanmugam M.K.; Ding L.; Xiang X.; Ho P.C.L.; Wang L.; Ong P.S.; Goh B.C.; Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Lett 2021,515,63-72","journal-title":"Cancer Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e2104826118","DOI":"10.1073\/pnas.2104826118","volume":"118","author":"Kong S.M.","year":"2021","unstructured":"Kong S.M.; Costa D.F.; Jagielska A.; Van Vliet K.J.; Hammond P.T.; Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration. Proc Natl Acad Sci USA 2021,118(42),e2104826118","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41467-017-02588-9","volume":"9","author":"Guo P.","year":"2018","unstructured":"Guo P.; Liu D.; Subramanyam K.; Wang B.; Yang J.; Huang J.; Auguste D.T.; Moses M.A.; Nanoparticle elasticity directs tumor uptake. Nat Commun 2018,9(1),130","journal-title":"Nat Commun"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1042\/BST0351156","volume":"35","author":"de la Lastra C.A.","year":"2007","unstructured":"de la Lastra C.A.; Villegas I.; Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem Soc Trans 2007,35(5),1156-1160","journal-title":"Biochem Soc Trans"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.fct.2015.01.017","volume":"78","author":"Posadino A.M.","year":"2015","unstructured":"Posadino A.M.; Cossu A.; Giordo R.; Zinellu A.; Sotgia S.; Vardeu A.; Hoa P.T.; Nguyen L.H.V.; Carru C.; Pintus G.; Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death. Food Chem Toxicol 2015,78,10-16","journal-title":"Food Chem Toxicol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/and.12132","volume":"46","author":"Ranawat P.","year":"2014","unstructured":"Ranawat P.; Khanduja K.L.; Pathak C.M.; Resveratrol - an ingredient of red wine abrogates the reproductive capacity in male mice. Andrologia 2014,46(6),650-658","journal-title":"Andrologia"},{"key":"ref=46","first-page":"621","volume":"23","author":"&#xD6;zyilmaz Yay.","year":"2019","unstructured":"&#xD6;zyilmaz Yay.; &#x15E;ener G.; Ercan F.; Resveratrol treatment reduces apoptosis and morphological alterations in cisplatin induced testis damage. J Res Pharm 2019,23(4),621-631","journal-title":"J Res Pharm"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.fct.2016.02.017","volume":"91","author":"Reddy K.P.","year":"2016","unstructured":"Reddy K.P.; Madhu P.; Reddy P.S.; Protective effects of resveratrol against cisplatin-induced testicular and epididymal toxicity in rats. Food Chem Toxicol 2016,91,65-72","journal-title":"Food Chem Toxicol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cbi.2017.05.024","volume":"273","author":"Singh I.","year":"2017","unstructured":"Singh I.; Goyal Y.; Ranawat P.; Potential chemoprotective role of resveratrol against cisplatin induced testicular damage in mice. Chem Biol Interact 2017,273,200-211","journal-title":"Chem Biol Interact"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/ijms21062084","volume":"21","author":"Shaito A.","year":"2020","unstructured":"Shaito A.; Posadino A.M.; Younes N.; Hasan H.; Halabi S.; Alhababi D.; Al-Mohannadi A.; Abdel-Rahman W.M.; Eid A.H.; Nasrallah G.K.; Pintus G.; Potential adverse effects of resveratrol: A literature review. Int J Mol Sci 2020,21(6),2084","journal-title":"Int J Mol Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/CCLM.1999.066","volume":"37","author":"Froelich J.J.","year":"1999","unstructured":"Froelich J.J.; Schneller F.R.; Zahn R.K.; The influence of radiation and chemotherapy-related DNA strand breaks on carcinogenesis: An evaluation. Clin Chem Lab Med 1999,37(4),403-408","journal-title":"Clin Chem Lab Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mrrev.2011.07.005","volume":"728","author":"Nambiar D.","year":"2011","unstructured":"Nambiar D.; Rajamani P.; Singh R.P.; Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat Res Rev Mutat Res 2011,728(3),139-157","journal-title":"Mutat Res Rev Mutat Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gde.2003.12.003","volume":"14","author":"Motoyama N.","year":"2004","unstructured":"Motoyama N.; Naka K.; DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev 2004,14(1),11-16","journal-title":"Curr Opin Genet Dev"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10495-009-0440-9","volume":"15","author":"Schonn I.","year":"2010","unstructured":"Schonn I.; Hennesen J.; Dartsch D.C.; Cellular responses to etoposide: Cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 2010,15(2),162-172","journal-title":"Apoptosis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"107995","DOI":"10.1016\/j.celrep.2020.107995","volume":"32","author":"Tsabar M.","year":"2020","unstructured":"Tsabar M.; Mock C.S.; Venkatachalam V.; Reyes J.; Karhohs K.W.; Oliver T.G.; Regev A.; Jambhekar A.; Lahav G.; A switch in p53 dynamics marks cells that escape from DSB-induced cell cycle arrest. Cell Rep 2020,32(5),107995","journal-title":"Cell Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1515\/tjb-2020-0320","volume":"46","author":"Sener T.E.","year":"2021","unstructured":"Sener T.E.; Atasoy B.M.; Cevik O.; Cilingir Kaya O.T.; Cetinel S.; Degerli A.D.; Sener G.; Effects of resveratrol against scattered radiation-induced testicular damage in rats. Turk Biyokim Derg 2021,46(4),425-433","journal-title":"Turk Biyokim Derg"},{"key":"ref=56","first-page":"149","volume":"197","author":"Dobrzy\u0144ska M.M.","year":"2022","unstructured":"Dobrzy\u0144ska M.M.; Gajowik A.; Protection and mitigation by resveratrol of DNA damage induced in irradiated human lymphocytes in vitro. Radiat Res 2022,197(2),149-156","journal-title":"Radiat Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/09553002.2019.1547440","volume":"95","author":"Mukherjee S.","year":"2019","unstructured":"Mukherjee S.; Chakraborty A.; Radiation-induced bystander phenomenon: Insight and implications in radiotherapy. Int J Radiat Biol 2019,95(3),243-263","journal-title":"Int J Radiat Biol"},{"key":"ref=58","first-page":"1","author":"Kocyigit A.","year":"2021","unstructured":"Kocyigit A.; Guler E.M.; In Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2021,1-14","journal-title":"In Handbook of Oxidative Stress in Cancer: Therapeutic Aspects"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","volume":"30","author":"Yang R.","year":"2021","unstructured":"Yang R.; Tan C.; Najafi M.; Cardiac inflammation and fibrosis following chemo\/radiation therapy: Mechanisms and therapeutic agents. Inflammopharmacology 2021,30(1),73-89","journal-title":"Inflammopharmacology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"108368","DOI":"10.1016\/j.mrrev.2021.108368","volume":"787","author":"Mukherjee S.","year":"2021","unstructured":"Mukherjee S.; Dutta A.; Chakraborty A.; External modulators and redox homeostasis: Scenario in radiation-induced bystander cells. Mutat Res Rev Mutat Res 2021,787,108368","journal-title":"Mutat Res Rev Mutat Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrrev.2018.08.001","volume":"778","author":"Burdak-Rothkamm S.","year":"2018","unstructured":"Burdak-Rothkamm S.; Rothkamm K.; Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses. Mutat Res Rev Mutat Res 2018,778,13-22","journal-title":"Mutat Res Rev Mutat Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jrr\/rrs142","volume":"54","author":"Zhang H.","year":"2013","unstructured":"Zhang H.; Wang Y.; Meng A.; Yan H.; Wang X.; Niu J.; Li J.; Wang H.; Inhibiting TGF&#x3B2;1 has a protective effect on mouse bone marrow suppression following ionizing radiation exposure in vitro. J Radiat Res (Tokyo) 2013,54(4),630-636","journal-title":"J Radiat Res (Tokyo)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2009.11.005","volume":"48","author":"Wang Y.","year":"2010","unstructured":"Wang Y.; Liu L.; Pazhanisamy S.K.; Li H.; Meng A.; Zhou D.; Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med 2010,48(2),348-356","journal-title":"Free Radic Biol Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/mutage\/ger001","volume":"26","author":"Pazhanisamy S.K.","year":"2011","unstructured":"Pazhanisamy S.K.; Li H.; Wang Y.; Batinic-Haberle I.; Zhou D.; NADPH oxidase inhibition attenuates total body irradiation-induced haematopoietic genomic instability. Mutagenesis 2011,26(3),431-435","journal-title":"Mutagenesis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2012.10.530","volume":"54","author":"Zhang H.","year":"2013","unstructured":"Zhang H.; Zhai Z.; Wang Y.; Zhang J.; Wu H.; Wang Y.; Li C.; Li D.; Lu L.; Wang X.; Chang J.; Hou Q.; Ju Z.; Zhou D.; Meng A.; Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med 2013,54,40-50","journal-title":"Free Radic Biol Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"108952","DOI":"10.1016\/j.abb.2021.108952","volume":"708","author":"Fu X.","year":"2021","unstructured":"Fu X.; Tang J.; Wen P.; Huang Z.; Najafi M.; Redox interactions-induced cardiac toxicity in cancer therapy. Arch Biochem Biophys 2021,708,108952","journal-title":"Arch Biochem Biophys"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.21873\/anticanres.13523","volume":"39","author":"Ivanova D.","year":"2019","unstructured":"Ivanova D.; Zhelev Z.; Semkova S.; Aoki I.; Bakalova R.; Resveratrol modulates the redox-status and Cytotoxicity of anticancer drugs by sensitizing leukemic lymphocytes and protecting normal lymphocytes. Anticancer Res 2019,39(7),3745-3755","journal-title":"Anticancer Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"109402","DOI":"10.1016\/j.cbi.2021.109402","volume":"338","author":"Ibrahim M.A.","year":"2021","unstructured":"Ibrahim M.A.; Albahlol I.A.; Wani F.A.; Abd-Eltawab Tammam A.; Kelleni M.T.; Sayeed M.U.; Abd El-Fadeal N.M.; Mohamed A.A.; Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis. Chem Biol Interact 2021,338,109402","journal-title":"Chem Biol Interact"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/10715762.2019.1614176","volume":"53","author":"Silva P.","year":"2019","unstructured":"Silva P.; Sureda A.; Tur J.A.; Andreoletti P.; Cherkaoui-Malki M.; Latruffe N.; How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process? Free Radical Res 2019,53(Supl),1101-1112","journal-title":"Free Radical Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/biof.1399","volume":"44","author":"Truong V.L.","year":"2018","unstructured":"Truong V.L.; Jun M.; Jeong W.S.; Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors 2018,44(1),36-49","journal-title":"Biofactors"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41443-018-0042-6","volume":"30","author":"Sener T.E.","year":"2018","unstructured":"Sener T.E.; Tavukcu H.H.; Atasoy B.M.; Cevik O.; Kaya O.T.; Cetinel S.; Dagli Degerli A.; Tinay I.; Simsek F.; Akbal C.; Buttic&#xE8; S.; Sener G.; Resveratrol treatment may preserve the erectile function after radiotherapy by restoring antioxidant defence mechanisms, SIRT1 and NOS protein expressions. Int J Impot Res 2018,30(4),179-188","journal-title":"Int J Impot Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3389\/fphar.2018.01268","volume":"9","author":"Ibrahim A.","year":"2018","unstructured":"Ibrahim A.; Al-Hizab F.A.; Abushouk A.I.; Abdel-Daim M.M.; Nephroprotective effects of benzyl isothiocyanate and resveratrol against cisplatin-induced oxidative stress and inflammation. Front Pharmacol 2018,9,1268","journal-title":"Front Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10637-017-0443-2","volume":"35","author":"Piska K.","year":"2017","unstructured":"Piska K.; Koczurkiewicz P.; Bucki A.; W&#xF3;jcik-Pszczo\u0142a K.; Ko\u0142aczkowski M.; P\u0119kala E.; Metabolic carbonyl reduction of anthracyclines \u2014 role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Invest New Drugs 2017,35(3),375-385","journal-title":"Invest New Drugs"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/1534735414564425","volume":"14","author":"Sheu M.T.","year":"2015","unstructured":"Sheu M.T.; Jhan H.J.; Hsieh C.M.; Wang C.J.; Ho H.O.; Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin. Integr Cancer Ther 2015,14(2),184-195","journal-title":"Integr Cancer Ther"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.18632\/aging.101808","volume":"11","author":"Wu M.","year":"2019","unstructured":"Wu M.; Ma L.; Xue L.; Ye W.; Lu Z.; Li X.; Jin Y.; Qin X.; Chen D.; Tang W.; Chen Y.; Hong Z.; Zhang J.; Luo A.; Wang S.; Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice. Aging (Albany NY) 2019,11(3),1030-1044","journal-title":"Aging (Albany NY)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1111\/febs.15583","volume":"288","author":"van der Zanden S.Y.","year":"2021","unstructured":"van der Zanden S.Y.; Qiao X.; Neefjes J.; New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J 2021,288(21),6095-6111","journal-title":"FEBS J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/10715760802673008","volume":"43","author":"Tatlidede E.","year":"2009","unstructured":"Tatlidede E.; &#x15E;ehirli &#xD6;.; Velio&#x11F;lu-&#xD6;&#x11F;&#xFC;n&#xE7; A.; &#xC7;etinel &#x15E;.; Ye&#x11F;en B.&#xC7;.; Yarat A.; S&#xFC;leymano&#x11F;lu S.; &#x15E;ener G.; Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radic Res 2009,43(3),195-205","journal-title":"Free Radic Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2016.01.002","volume":"32","author":"Gu J.","year":"2016","unstructured":"Gu J.; Hu W.; Song Z.; Chen Y.; Zhang D.; Wang C.; Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity. Int Immunopharmacol 2016,32,1-7","journal-title":"Int Immunopharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"110234","DOI":"10.1016\/j.biopha.2020.110234","volume":"127","author":"Farkhondeh T.","year":"2020","unstructured":"Farkhondeh T.; Folgado S.L.; Pourbagher-Shahri A.M.; Ashrafizadeh M.; Samarghandian S.; The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway. Biomed Pharmacother 2020,127,110234","journal-title":"Biomed Pharmacother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1051\/radiopro\/2018034","volume":"53","author":"Salehi S.","year":"2018","unstructured":"Salehi S.; Bayatiani M.R.; Yaghmaei P.; Rajabi S.; Goodarzi M.T.; Jalali Mashayekhi F.; Protective effects of resveratrol against X-ray irradiation by regulating antioxidant defense system. Radioprotection 2018,53(4),293-298","journal-title":"Radioprotection"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12906-017-1915-9","volume":"17","author":"Zhang H.","year":"2017","unstructured":"Zhang H.; Yan H.; Zhou X.; Wang H.; Yang Y.; Zhang J.; Wang H.; The protective effects of resveratrol against radiation-induced intestinal injury. BMC Complement Altern Med 2017,17(1),410-410","journal-title":"BMC Complement Altern Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"282657","DOI":"10.1155\/2014\/282657","volume":"2014","author":"Wang H.","year":"2014","unstructured":"Wang H.; Yang Y.; Zhang H.; Yan H.; Wu X.; Zhang C.; Administration of the resveratrol analogues isorhapontigenin and heyneanol-A protects mice hematopoietic cells against irradiation injuries. BioMed Res Int 2014,2014,282657","journal-title":"BioMed Res Int"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3835(98)00250-X","volume":"134","author":"Jang M.","year":"1998","unstructured":"Jang M.; Pezzuto J.M.; Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 1998,134(1),81-89","journal-title":"Cancer Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.taap.2006.12.025","volume":"224","author":"Athar M.","year":"2007","unstructured":"Athar M.; Back J.; Tang X.; Kim K.; Kopelovich L.; Bickers D.; Kim A.; Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007,224(3),274-283","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0753-3322(01)00158-5","volume":"56","author":"Savouret J.F.","year":"2002","unstructured":"Savouret J.F.; Quesne M.; Resveratrol and cancer: A review. Biomed Pharmacother 2002,56(2),84-87","journal-title":"Biomed Pharmacother"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/0008-5472.CAN-03-2404","volume":"64","author":"Opipari A.W.","year":"2004","unstructured":"Opipari A.W.; Tan L.; Boitano A.E.; Sorenson D.R.; Aurora A.; Liu J.R.; Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 2004,64(2),696-703","journal-title":"Cancer Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"Anderson N.M.","year":"2020","unstructured":"Anderson N.M.; Simon M.C.; The tumor microenvironment. Curr Biol 2020,30(16),R921-R925","journal-title":"Curr Biol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"Jin M.Z.","year":"2020","unstructured":"Jin M.Z.; Jin W.L.; The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther 2020,5(1),166","journal-title":"Signal Transduct Target Ther"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"Hinshaw D.C.","year":"2019","unstructured":"Hinshaw D.C.; Shevde L.A.; The tumor microenvironment innately modulates cancer progression. Cancer Res 2019,79(18),4557-4566","journal-title":"Cancer Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"152729","DOI":"10.1016\/j.prp.2019.152729","volume":"216","author":"Ribeiro Franco P.I.","year":"2020","unstructured":"Ribeiro Franco P.I.; Rodrigues A.P.; de Menezes L.B.; Pacheco Miguel M.; Tumor microenvironment components: Allies of cancer progression. Pathol Res Pract 2020,216(1),152729","journal-title":"Pathol Res Pract"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms20040840","volume":"20","author":"Roma-Rodrigues C.","year":"2019","unstructured":"Roma-Rodrigues C.; Mendes R.; Baptista P.; Fernandes A.; Targeting tumor microenvironment for cancer therapy. Int J Mol Sci 2019,20(4),840","journal-title":"Int J Mol Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.intimp.2014.07.004","volume":"22","author":"Jeong S.K.","year":"2014","unstructured":"Jeong S.K.; Yang K.; Park Y.S.; Choi Y.J.; Oh S.J.; Lee C.W.; Lee K.Y.; Jeong M.H.; Jo W.S.; Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages. Int Immunopharmacol 2014,22(2),303-310","journal-title":"Int Immunopharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"108624","DOI":"10.1016\/j.jnutbio.2021.108624","volume":"92","author":"Pradhan R.","year":"2021","unstructured":"Pradhan R.; Chatterjee S.; Hembram K.C.; Sethy C.; Mandal M.; Kundu C.N.; Nano formulated resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. J Nutr Biochem 2021,92,108624","journal-title":"J Nutr Biochem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1111\/cas.13720","volume":"109","author":"Zhao Y.","year":"2018","unstructured":"Zhao Y.; Shao Q.; Zhu H.; Xu H.; Long W.; Yu B.; Zhou L.; Xu H.; Wu Y.; Su Z.; Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability. Cancer Sci 2018,109(9),2677-2686","journal-title":"Cancer Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"105864","DOI":"10.1016\/j.ejps.2021.105864","volume":"163","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Ma J.; Qiu T.; Tang M.; Zhang X.; Dong W.; In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer. Eur J Pharm Sci 2021,163,105864","journal-title":"Eur J Pharm Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.intimp.2007.12.006","volume":"8","author":"Yang Y.","year":"2008","unstructured":"Yang Y.; Paik J.H.; Cho D.; Cho J.A.; Kim C.W.; Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int Immunopharmacol 2008,8(4),542-547","journal-title":"Int Immunopharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3892\/etm.2012.472","volume":"3","author":"Choi Y.J.","year":"2012","unstructured":"Choi Y.J.; Yang K.M.; Kim S.D.; Yoo Y.H.; Lee S.W.; Seo S.Y.; Suh H.; Yee S.T.; Jeong M.H.; Jo W.S.; Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells. Exp Ther Med 2012,3(4),592-598","journal-title":"Exp Ther Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"106905","DOI":"10.1016\/j.intimp.2020.106905","volume":"88","author":"Davoodvandi A.","year":"2020","unstructured":"Davoodvandi A.; Darvish M.; Borran S.; Nejati M.; Mazaheri S.; Reza Tamtaji O.; Hamblin M.R.; Masoudian N.; Mirzaei H.; The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. Int Immunopharmacol 2020,88,106905","journal-title":"Int Immunopharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1829346","DOI":"10.1080\/2162402X.2020.1829346","volume":"9","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Huang H.; Zheng F.; Liu H.; Qiu F.; Chen Y.; Liang C.L.; Dai Z.; Resveratrol exerts antitumor effects by downregulating CD8 + CD122 + Tregs in murine hepatocellular carcinoma. OncoImmunology 2020,9(1),1829346-1829346","journal-title":"OncoImmunology"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jss.2006.05.037","volume":"138","author":"Golkar L.","year":"2007","unstructured":"Golkar L.; Ding X.Z.; Ujiki M.B.; Salabat M.R.; Kelly D.L.; Scholtens D.; Fought A.J.; Bentrem D.J.; Talamonti M.S.; Bell R.H.; Adrian T.E.; Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res 2007,138(2),163-169","journal-title":"J Surg Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"104423","DOI":"10.1016\/j.cellimm.2021.104423","volume":"368","author":"Han X.","year":"2021","unstructured":"Han X.; Zhao N.; Zhu W.; Wang J.; Liu B.; Teng Y.; Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model. Cell Immunol 2021,368,104423","journal-title":"Cell Immunol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00262-018-2130-3","volume":"67","author":"Mukherjee S.","year":"2018","unstructured":"Mukherjee S.; Hussaini R.; White R.; Atwi D.; Fried A.; Sampat S.; Piao L.; Pan Q.; Banerjee P.; TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors. Cancer Immunol Immunother 2018,67(5),761-774","journal-title":"Cancer Immunol Immunother"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/adt.2020.972","volume":"18","author":"Singh V.","year":"2020","unstructured":"Singh V.; Singh R.; Kujur P.K.; Singh R.P.; Combination of resveratrol and quercetin causes cell growth inhibition, DNA damage, cell cycle arrest, and apoptosis in oral cancer cells. Assay Drug Dev Technol 2020,18(5),226-238","journal-title":"Assay Drug Dev Technol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.12998\/wjcc.v8.i12.2425","volume":"8","author":"Wang L.Y.","year":"2020","unstructured":"Wang L.Y.; Zhao S.; Lv G.J.; Ma X.J.; Zhang J.B.; Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer. World J Clin Cases 2020,8(12),2425-2437","journal-title":"World J Clin Cases"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"BSR20200257","DOI":"10.1042\/BSR20200257","volume":"40","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Javanmardi S.; Moradi-Ozarlou M.; Mohammadinejad R.; Farkhondeh T.; Samarghandian S.; Garg M.; Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: An updated review on resveratrol. Biosci Rep 2020,40(4),BSR20200257","journal-title":"Biosci Rep"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3892\/ijmm.2020.4539","volume":"45","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Guo L.; Law B.; Liang X.; Ma N.; Xu G.; Wang X.; Yuan X.; Tang H.; Chen Q.; Wong V.; Wang X.; Resveratrol decreases cell apoptosis through inhibiting DNA damage in bronchial epithelial cells. Int J Mol Med 2020,45(6),1673-1684","journal-title":"Int J Mol Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.yexcr.2018.06.031","volume":"370","author":"Ji S.","year":"2018","unstructured":"Ji S.; Zheng Z.; Liu S.; Ren G.; Gao J.; Zhang Y.; Li G.; Resveratrol promotes oxidative stress to drive DLC1 mediated cellular senescence in cancer cells. Exp Cell Res 2018,370(2),292-302","journal-title":"Exp Cell Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2014.07.034","volume":"75","author":"Tamaki N.","year":"2014","unstructured":"Tamaki N.; Cristina Orihuela-Campos R.; Inagaki Y.; Fukui M.; Nagata T.; Ito H.O.; Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1\/AMPK and the Nrf2\/antioxidant defense pathways in a rat periodontitis model. Free Radic Biol Med 2014,75,222-229","journal-title":"Free Radic Biol Med"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2174\/1871520620666201020160348","volume":"21","author":"Ashrafizadeh M.","year":"2021","unstructured":"Ashrafizadeh M.; Taeb S.; Haghi-Aminjan H.; Afrashi S.; Moloudi K.; Musa A.E.; Najafi M.; Farhood B.; Resveratrol as an enhancer of apoptosis in cancer: A mechanistic review. Anticancer Agents Med Chem 2021,21(17),2327-2336","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CEJ.0b013e328353edcb","volume":"22","author":"Leon-Galicia I.","year":"2013","unstructured":"Leon-Galicia I.; Diaz-Chavez J.; Garcia-Villa E.; Uribe-Figueroa L.; Hidalgo-Miranda A.; Herrera L.A.; Alvarez-Rios E.; Garcia-Mena J.; Gariglio P.; Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. Eur J Cancer Prev 2013,22(1),11-20","journal-title":"Eur J Cancer Prev"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.3892\/or.2018.6336","volume":"39","author":"Leon-Galicia I.","year":"2018","unstructured":"Leon-Galicia I.; Diaz-Chavez J.; Albino-Sanchez M.E.; Garcia-Villa E.; Bermudez-Cruz R.; Garcia-Mena J.; Herrera L.A.; Garc&#xED;a-Carranc&#xE1; A.; Gariglio P.; Resveratrol decreases Rad51 expression and sensitizes cisplatin resistant MCF 7 breast cancer cells. Oncol Rep 2018,39(6),3025-3033","journal-title":"Oncol Rep"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2493869","DOI":"10.1155\/2018\/2493869","volume":"2018","author":"Ru&#xED;z G.","year":"2018","unstructured":"Ru&#xED;z G.; Valencia-Gonz&#xE1;lez H.A.; Le&#xF3;n-Galicia I.; Garc&#xED;a-Villa E.; Garc&#xED;a-Carranc&#xE1; A.; Gariglio P.; Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis. Stem Cells Int 2018,2018,2493869","journal-title":"Stem Cells Int"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/bcpt.12425","volume":"117","author":"Ko J.C.","year":"2015","unstructured":"Ko J.C.; Syu J.J.; Chen J.C.; Wang T.J.; Chang P.Y.; Chen C.Y.; Jian Y.T.; Jian Y.J.; Lin Y.W.; Resveratrol enhances etoposide-induced cytotoxicity through down-regulating ERK1\/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) protein expression in human non-small-cell lung cancer cells. Basic Clin Pharmacol Toxicol 2015,117(6),383-391","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1002\/jcp.28504","volume":"234","author":"Mortezaee K.","year":"2019","unstructured":"Mortezaee K.; Najafi M.; Farhood B.; Ahmadi A.; Shabeeb D.; Musa A.E.; NF-&#x3BA;B targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019,234(10),17187-17204","journal-title":"J Cell Physiol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3892\/or.2011.1598","volume":"27","author":"Huang H.","year":"2012","unstructured":"Huang H.; Lin H.; Zhang X.; Li J.; Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-&#x3BA;B-dependent pathway. Oncol Rep 2012,27(6),2050-2056","journal-title":"Oncol Rep"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/bcpt.13648","volume":"129","author":"Yu C.","year":"2021","unstructured":"Yu C.; Yang B.; Najafi M.; Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic Clin Pharmacol Toxicol 2021,129(6),397-415","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","volume":"36","author":"Siska P.J.","year":"2015","unstructured":"Siska P.J.; Rathmell J.C.; T cell metabolic fitness in antitumor immunity. Trends Immunol 2015,36(4),257-264","journal-title":"Trends Immunol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gde.2007.12.007","volume":"18","author":"Ostrand-Rosenberg S.","year":"2008","unstructured":"Ostrand-Rosenberg S.; Immune surveillance: A balance between protumor and antitumor immunity. Curr Opin Genet Dev 2008,18(1),11-18","journal-title":"Curr Opin Genet Dev"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/1871520614666140521121722","volume":"14","author":"Yang X.","year":"2014","unstructured":"Yang X.; Li X.; Ren J.; From French paradox to cancer treatment: Anti-Cancer activities and mechanisms of resveratrol. Anticancer Agents Med Chem 2014,14(6),806-825","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jcb.22691","volume":"111","author":"Zheng T.","year":"2010","unstructured":"Zheng T.; Meng X.; Wang J.; Chen X.; Yin D.; Liang Y.; Song X.; Pan S.; Jiang H.; Liu L.; PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. J Cell Biochem 2010,111(1),218-228","journal-title":"J Cell Biochem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nrd2656","volume":"7","author":"Vazquez A.","year":"2008","unstructured":"Vazquez A.; Bond E.E.; Levine A.J.; Bond G.L.; The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008,7(12),979-987","journal-title":"Nat Rev Drug Discov"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/156800908784293659","volume":"8","author":"Carnero A.","year":"2008","unstructured":"Carnero A.; Blanco-Aparicio C.; Renner O.; Link W.; Leal J.; The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008,8(3),187-198","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.3892\/ol.2019.10034","volume":"17","author":"Liu Z.","year":"2019","unstructured":"Liu Z.; Wu X.; Lv J.; Sun H.; Zhou F.; Resveratrol induces p53 in colorectal cancer through SET7\/9. Oncol Lett 2019,17(4),3783-3789","journal-title":"Oncol Lett"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1074\/jbc.M501250200","volume":"280","author":"Borra M.T.","year":"2005","unstructured":"Borra M.T.; Smith B.C.; Denu J.M.; Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005,280(17),17187-17195","journal-title":"J Biol Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"27214","DOI":"10.18632\/oncotarget.4877","volume":"6","author":"Dhar S.","year":"2015","unstructured":"Dhar S.; Kumar A.; Rimando A.M.; Zhang X.; Levenson A.S.; Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget 2015,6(29),27214-27226","journal-title":"Oncotarget"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpba.2016.10.015","volume":"133","author":"Kumar A.","year":"2017","unstructured":"Kumar A.; Devineni S.R.; Dubey S.K.; Kumar P.; Srivastava V.; Ambulgekar G.; Jain M.; Gupta D.K.; Singh G.; Kumar R.; Hiriyanna S.G.; Kumar P.; Identification, synthesis and structural characterization of process related and degradation impurities of acrivastine and validation of HPLC method. J Pharm Biomed Anal 2017,133,15-26","journal-title":"J Pharm Biomed Anal"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/cancers12082134","volume":"12","author":"Wyld L.","year":"2020","unstructured":"Wyld L.; Bellantuono I.; Tchkonia T.; Morgan J.; Turner O.; Foss F.; George J.; Danson S.; Kirkland J.L.; Senescence and cancer: A review of clinical implications of senescence and senotherapies. Cancers (Basel) 2020,12(8),2134","journal-title":"Cancers (Basel)"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/ctm.ctm_22_18","volume":"4","author":"Shen W.H.","year":"2018","unstructured":"Shen W.H.; Liu L.; Zeng S.; Senescence and cancer. Cancer Transl Med 2018,4(3),70-74","journal-title":"Cancer Transl Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41598-017-00315-4","volume":"7","author":"Li B.","year":"2017","unstructured":"Li B.; Hou D.; Guo H.; Zhou H.; Zhang S.; Xu X.; Liu Q.; Zhang X.; Zou Y.; Gong Y.; Shao C.; Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Sci Rep 2017,7(1),208","journal-title":"Sci Rep"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mnfr.200500149","volume":"50","author":"Young L.F.","year":"2006","unstructured":"Young L.F.; Martin K.R.; Time-dependent resveratrol-mediated mRNA and protein expression associated with cell cycle in WR-21 cells containing mutated human c-Ha-Ras. Mol Nutr Food Res 2006,50(1),70-77","journal-title":"Mol Nutr Food Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"e0127386","DOI":"10.1371\/journal.pone.0127386","volume":"10","author":"Zhang M.","year":"2015","unstructured":"Zhang M.; Harashima N.; Moritani T.; Huang W.; Harada M.; The roles of ROS and caspases in TRAIL-induced apoptosis and necroptosis in human pancreatic cancer cells. PLoS One 2015,10(5),e0127386","journal-title":"PLoS One"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s12253-011-9433-4","volume":"17","author":"Dunai Z.","year":"2011","unstructured":"Dunai Z.; Bauer P.I.; Mihalik R.; Necroptosis: Biochemical, physiological and pathological aspects. Pathol Oncol Res 2011,17(4),791-800","journal-title":"Pathol Oncol Res"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1044-579X(02)00133-5","volume":"Vol. 13","author":"Folkman J.","year":"2003","unstructured":"Folkman J.; Angiogenesis and apoptosis. Seminars in Cancer Biology 2003,Vol. 13,159-167","journal-title":"Seminars in Cancer Biology"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11060-006-9172-7","volume":"80","author":"Zhang P.","year":"2006","unstructured":"Zhang P.; Li H.; Wu M.L.; Chen X.Y.; Kong Q.Y.; Wang X.W.; Sun Y.; Wen S.; Liu J.; c-Myc downregulation: A critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol 2006,80(2),123-131","journal-title":"J Neurooncol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"65743","DOI":"10.18632\/oncotarget.19445","volume":"8","author":"Pan J.","year":"2017","unstructured":"Pan J.; Shen J.; Si W.; Du C.; Chen D.; Xu L.; Yao M.; Fu P.; Fan W.; Resveratrol promotes MICA\/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc\/miR-17 pathway. Oncotarget 2017,8(39),65743-65758","journal-title":"Oncotarget"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/ol.2018.8772","volume":"16","author":"Dai H.","year":"2018","unstructured":"Dai H.; Deng H.B.; Wang Y.H.; Guo J.J.; Resveratrol inhibits the growth of gastric cancer via the Wnt\/&#x3B2;-catenin pathway. Oncol Lett 2018,16(2),1579-1583","journal-title":"Oncol Lett"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"e78700","DOI":"10.1371\/journal.pone.0078700","volume":"8","author":"Ji Q.","year":"2013","unstructured":"Ji Q.; Liu X.; Fu X.; Zhang L.; Sui H.; Zhou L.; Sun J.; Cai J.; Qin J.; Ren J.; Li Q.; Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt\/&#x3B2;-catenin signal pathway. PLoS One 2013,8(11),e78700-e78700","journal-title":"PLoS One"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"326","DOI":"10.12688\/f1000research.11771.1","volume":"7","author":"Ma S.","year":"2018","unstructured":"Ma S.; Pradeep S.; Hu W.; Zhang D.; Coleman R.; Sood A.; The role of tumor microenvironment in resistance to anti-angiogenic therapy. F1000 Res 2018,7,326-326","journal-title":"F1000 Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"0963689720929987","DOI":"10.1177\/0963689720929987","volume":"29","author":"Xiao Y.","year":"2020","unstructured":"Xiao Y.; Qin T.; Sun L.; Qian W.; Li J.; Duan W.; Lei J.; Wang Z.; Ma J.; Li X.; Ma Q.; Xu Q.; Resveratrol ameliorates the malignant progression of pancreatic cancer by inhibiting hypoxia-induced pancreatic stellate cell activation. Cell Transplant 2020,29,0963689720929987","journal-title":"Cell Transplant"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3892\/ijo.2017.4058","volume":"51","author":"Kim D.H.","year":"2017","unstructured":"Kim D.H.; Sung B.; Kim J.A.; Kang Y.J.; Hwang S.Y.; Hwang N.L.; Suh H.; Choi Y.H.; Im, E.; Chung, H.Y.; Kim, N.D. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model. Int J Oncol 2017,51(2),715-723","journal-title":"Int J Oncol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","volume":"141","author":"Seghezzi G.","year":"1998","unstructured":"Seghezzi G.; Patel S.; Ren C.J.; Gualandris A.; Pintucci G.; Robbins E.S.; Shapiro R.L.; Galloway A.C.; Rifkin D.B.; Mignatti P.; Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 1998,141(7),1659-1673","journal-title":"J Cell Biol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1096\/fj.01-0028fje","volume":"15","author":"Br&#xE2;kenhielm E.","year":"2001","unstructured":"Br&#xE2;kenhielm E.; Cao R.; Cao Y.; Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001,15(10),1798-1800","journal-title":"FASEB J"},{"key":"ref=143","first-page":"273","volume":"35","author":"Wong J.C.","year":"2015","unstructured":"Wong J.C.; Fiscus R.R.; Resveratrol at anti-angiogenesis\/anticancer concentrations suppresses protein kinase G signaling and decreases IAPs expression in HUVECs. Anticancer Res 2015,35(1),273-281","journal-title":"Anticancer Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/01635581.2016.1158295","volume":"68","author":"Kimura Y.","year":"2016","unstructured":"Kimura Y.; Sumiyoshi M.; Resveratrol prevents tumor growth and metastasis by inhibiting lymphangiogenesis and M2 macrophage activation and differentiation in tumor-associated macrophages. Nutr Cancer 2016,68(4),667-678","journal-title":"Nutr Cancer"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"111091","DOI":"10.1016\/j.fct.2019.111091","volume":"137","author":"Delmas D.","year":"2020","unstructured":"Delmas D.; Limagne E.; Ghiringhelli F.; Aires V.; Immune Th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol. Food Chem Toxicol 2020,137,111091","journal-title":"Food Chem Toxicol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"107895","DOI":"10.1016\/j.intimp.2021.107895","volume":"98","author":"Mu Q.","year":"2021","unstructured":"Mu Q.; Najafi M.; Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. Int Immunopharmacol 2021,98,107895","journal-title":"Int Immunopharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"Farhood B.","year":"2020","unstructured":"Farhood B.; khodamoradi, E.; Hoseini-Ghahfarokhi, M.; Motevaseli, E.; Mirtavoos-Mahyari, H.; Eleojo Musa, A.; Najafi, M. TGF-&#x3B2; in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 2020,155,104745","journal-title":"Pharmacol Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3835(01)00443-8","volume":"171","author":"Igura K.","year":"2001","unstructured":"Igura K.; Ohta T.; Kuroda Y.; Kaji K.; Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001,171(1),11-16","journal-title":"Cancer Lett"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10456-010-9187-8","volume":"13","author":"Trapp V.","year":"2010","unstructured":"Trapp V.; Parmakhtiar B.; Papazian V.; Willmott L.; Fruehauf J.P.; Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis 2010,13(4),305-315","journal-title":"Angiogenesis"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1166\/jbn.2019.2682","volume":"15","author":"Zhang D.","year":"2019","unstructured":"Zhang D.; Zhang J.; Zeng J.; Li Z.; Zuo H.; Huang C.; Zhao X.; Nano-gold loaded with resveratrol enhance the anti-hepatoma effect of resveratrol in vitro and in vivo. J Biomed Nanotechnol 2019,15(2),288-300","journal-title":"J Biomed Nanotechnol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1002\/ptr.7189","volume":"35","author":"Chen L.","year":"2021","unstructured":"Chen L.; Musa A.E.; Boosting immune system against cancer by resveratrol. Phytother Res 2021,35(10),5514-5526","journal-title":"Phytother Res"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.phymed.2016.02.011","volume":"23","author":"Baek S.H.","year":"2016","unstructured":"Baek S.H.; Ko J.H.; Lee H.; Jung J.; Kong M.; Lee J.; Lee J.; Chinnathambi A.; Zayed M.E.; Alharbi S.A.; Lee S.G.; Shim B.S.; Sethi G.; Kim S.H.; Yang W.M.; Um J.Y.; Ahn K.S.; Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine 2016,23(5),566-577","journal-title":"Phytomedicine"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1269\/jrr.46.387","volume":"46","author":"Liao H.F.","year":"2005","unstructured":"Liao H.F.; Kuo C.D.; Yang Y.C.; Lin C.P.; Tai H.C.; Chen Y.Y.; Chen Y.J.; Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res (Tokyo) 2005,46(4),387-393","journal-title":"J Radiat Res (Tokyo)"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"Taniguchi K.","year":"2018","unstructured":"Taniguchi K.; Karin, M. NF-&#x3BA;B, inflammation, immunity and cancer: Coming of age. Nat Rev Immunol 2018,18(5),309-324","journal-title":"Nat Rev Immunol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000491730","volume":"48","author":"Ji K.","year":"2018","unstructured":"Ji K.; Sun X.; Liu Y.; Du L.; Wang Y.; He N.; Wang J.; Xu C.; Liu Q.; Regulation of apoptosis and radiation sensitization in lung cancer cells via the Sirt1\/NF-&#x3BA;B\/Smac pathway. Cell Physiol Biochem 2018,48(1),304-316","journal-title":"Cell Physiol Biochem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1349-7006.2012.02272.x","volume":"103","author":"Fang Y.","year":"2012","unstructured":"Fang Y.; DeMarco V.G.; Nicholl M.B.; Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 2012,103(6),1090-1098","journal-title":"Cancer Sci"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s42003-020-0811-x","volume":"3","author":"Grimaldi A.","year":"2020","unstructured":"Grimaldi A.; Cammarata I.; Martire C.; Focaccetti C.; Piconese S.; Buccilli M.; Mancone C.; Buzzacchino F.; Berrios J.R.G.; D\u2019Alessandris N.; Tomao S.; Giangaspero F.; Paroli M.; Caccavale R.; Spinelli G.P.; Girelli G.; Peruzzi G.; Nistic&#xF2; P.; Spada S.; Panetta M.; Letizia Cecere F.; Visca P.; Facciolo F.; Longo F.; Barnaba V.; Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens. Commun Biol 2020,3(1),85","journal-title":"Commun Biol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1177\/1535370215573396","volume":"240","author":"Dun J.","year":"2015","unstructured":"Dun J.; Chen X.; Gao H.; Zhang Y.; Zhang H.; Zhang Y.; Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. Exp Biol Med (Maywood) 2015,240(12),1672-1681","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.3748\/wjg.v10.i20.3048","volume":"10","author":"Wu S.L.","year":"2004","unstructured":"Wu S.L.; Sun Z-J.; Yu L.; Meng K-W.; Qin X-L.; Pan C-E.; Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 2004,10(20),3048-3052","journal-title":"World J Gastroenterol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.bcp.2008.08.002","volume":"76","author":"Komina O.","year":"2008","unstructured":"Komina O.; W\u0119sierska-G\u0105dek J.; Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells. Biochem Pharmacol 2008,76(11),1554-1562","journal-title":"Biochem Pharmacol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12935-020-01185-z","volume":"20","author":"Dai C.","year":"2020","unstructured":"Dai C.; Zhang Y.; Xu Z.; Jin M.; MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma. Cancer Cell Int 2020,20(1),98","journal-title":"Cancer Cell Int"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"16283","DOI":"10.1002\/jcb.28910","volume":"120","author":"Zhang W.","year":"2019","unstructured":"Zhang W.; Jiang H.; Chen Y.; Ren F.; Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p. J Cell Biochem 2019,120(9),16283-16292","journal-title":"J Cell Biochem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/nu10091148","volume":"10","author":"Hernandez-Valencia J.","year":"2018","unstructured":"Hernandez-Valencia J.; Garcia-Villa E.; Arenas-Hernandez A.; Garcia-Mena J.; Diaz-Chavez J.; Gariglio P.; Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin. Nutrients 2018,10(9),1148","journal-title":"Nutrients"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1196\/annals.1397.047","volume":"1095","author":"Hwang J.T.","year":"2007","unstructured":"Hwang J.T.; Kwak D.W.; Lin S.K.; Kim H.M.; Kim Y.M.; Park O.J.; Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci 2007,1095(1),441-448","journal-title":"Ann N Y Acad Sci"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cam4.1993","volume":"8","author":"Jin X.","year":"2019","unstructured":"Jin X.; Wei Y.; Liu Y.; Lu X.; Ding F.; Wang J.; Yang S.; Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1\/&#x3B2;-catenin signaling pathway in breast cancer. Cancer Med 2019,8(3),1246-1257","journal-title":"Cancer Med"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/iub.1749","volume":"70","author":"Chen J.M.","year":"2018","unstructured":"Chen J.M.; Bai J.Y.; Yang K.X.; Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K\/Akt signaling pathway. IUBMB Life 2018,70(6),491-500","journal-title":"IUBMB Life"},{"key":"ref=167","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12514","volume":"52","author":"Zhou C.","year":"2019","unstructured":"Zhou C.; Qian W.; Ma J.; Cheng L.; Jiang Z.; Yan B.; Li J.; Duan W.; Sun L.; Cao J.; Wang F.; Wu E.; Wu Z.; Ma Q.; Li X.; Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif 2019,52(1)","journal-title":"Cell Prolif"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1039\/C8RA08364A","volume":"9","author":"Huang L.","year":"2019","unstructured":"Huang L.; Zhang S.; Zhou J.; Li X.; Effect of resveratrol on drug resistance in colon cancer chemotherapy. RSC Advances 2019,9(5),2572-2580","journal-title":"RSC Advances"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"571","DOI":"10.24425\/pjvs.2020.135803","author":"Uvez A.","year":"2020","unstructured":"Uvez A.; Aydinlik S.; Esener O.; Erkisa M.; Karakus D.; Armutak E.; Synergistic interactions between resveratrol and doxorubicin inhibit angiogenesis both in vitro and in vivo. Pol J Vet Sci 2020,571-580","journal-title":"Pol J Vet Sci"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.25041","volume":"127","author":"Harikumar K.B.","year":"2010","unstructured":"Harikumar K.B.; Kunnumakkara A.B.; Sethi G.; Diagaradjane P.; Anand P.; Pandey M.K.; Gelovani J.; Krishnan S.; Guha S.; Aggarwal B.B.; Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 2010,127(2),257-268","journal-title":"Int J Cancer"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.3892\/mmr.2015.3675","volume":"12","author":"Lee S.H.","year":"2015","unstructured":"Lee S.H.; Koo B.S.; Park S.Y.; Kim Y.M.; Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells. Mol Med Rep 2015,12(2),2777-2783","journal-title":"Mol Med Rep"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"Noorolyai S.","year":"2019","unstructured":"Noorolyai S.; Shajari N.; Baghbani E.; Sadreddini S.; Baradaran B.; The relation between PI3K\/AKT signalling pathway and cancer. Gene 2019,698,120-128","journal-title":"Gene"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"6612365","DOI":"10.1155\/2021\/6612365","volume":"2021","author":"Han Y.","year":"2021","unstructured":"Han Y.; Ma R.; Cao G.; Liu H.; He L.; Tang L.; Li H.; Luo Q.; Combined treatment of cinobufotalin and gefitinib exhibits potent efficacy against lung cancer. Evid Based Complement Altern Med 2021,2021,6612365","journal-title":"Evid Based Complement Altern Med"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"17730","DOI":"10.1038\/srep17730","volume":"5","author":"Zhu Y.","year":"2015","unstructured":"Zhu Y.; He W.; Gao X.; Li B.; Mei C.; Xu R.; Chen H.; Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9\/G NSCLC cells. Sci Rep 2015,5(1),17730","journal-title":"Sci Rep"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1159\/000374030","volume":"35","author":"Nie P.","year":"2015","unstructured":"Nie P.; Hu W.; Zhang T.; Yang Y.; Hou B.; Zou Z.; Synergistic induction of erlotinib-mediated apoptosis by resveratrol in human non-small-cell lung cancer cells by down-regulating survivin and up-regulating PUMA. Cell Physiol Biochem 2015,35(6),2255-2271","journal-title":"Cell Physiol Biochem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1038\/srep12054","volume":"5","author":"Abdel-Latif G.A.","year":"2015","unstructured":"Abdel-Latif G.A.; Al-Abd A.M.; Tadros M.G.; Al-Abbasi F.A.; Khalifa A.E.; Abdel-Naim A.B.; The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines. Sci Rep 2015,5(1),12054","journal-title":"Sci Rep"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"106663","DOI":"10.1016\/j.intimp.2020.106663","volume":"85","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Rezaeyan A.; Najafi M.; Abscopal effect in radioimmunotherapy. Int Immunopharmacol 2020,85,106663","journal-title":"Int Immunopharmacol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"108707","DOI":"10.1016\/j.clim.2021.108707","volume":"226","author":"Majidpoor J.","year":"2021","unstructured":"Majidpoor J.; Mortezaee K.; The efficacy of PD-1\/PD-L1 blockade in cold cancers and future perspectives. Clin Immunol 2021,226,108707","journal-title":"Clin Immunol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"103180","DOI":"10.1016\/j.critrevonc.2020.103180","volume":"157","author":"Mortezaee K.","year":"2021","unstructured":"Mortezaee K.; Najafi M.; Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. Crit Rev Oncol Hematol 2021,157,103180","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12079-021-00648-w","volume":"16","author":"Wu Z.","year":"2021","unstructured":"Wu Z.; Zhang C.; Najafi M.; Targeting of the tumor immune microenvironment by metformin. J Cell Commun Signal 2021,16(3),333-348","journal-title":"J Cell Commun Signal"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biof.1776","volume":"47","author":"Fu X.","year":"2021","unstructured":"Fu X.; He Y.; Li M.; Huang Z.; Najafi M.; Targeting of the tumor microenvironment by curcumin. Biofactors 2021,47(6),914-932","journal-title":"Biofactors"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"8","DOI":"10.18632\/aging.102646","volume":"12","author":"Verdura S.","year":"2020","unstructured":"Verdura S.; Cuy&#xE0;s E.; Cortada E.; Brunet J.; Lopez-Bonet E.; Martin-Castillo B.; Bosch-Barrera J.; Encinar J.A.; Menendez J.A.; Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging (Albany NY) 2020,12(1),8-34","journal-title":"Aging (Albany NY)"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3892\/ijo.2018.4512","volume":"53","author":"Lucas J.","year":"2018","unstructured":"Lucas J.; Hsieh T.C.; Halicka H.D.; Darzynkiewicz Z.; Wu J.; Upregulation of PD L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3\/p300 mediated NF &#x3BA;B signaling. Int J Oncol 2018,53(4),1469-1480","journal-title":"Int J Oncol"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00432-021-03510-z","volume":"147","author":"Yang M.","year":"2021","unstructured":"Yang M.; Li Z.; Tao J.; Hu H.; Li Z.; Zhang Z.; Cheng F.; Sun Y.; Zhang Y.; Yang J.; Wei H.; Wu Z.; Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells. J Cancer Res Clin Oncol 2021,147(4),1101-1113","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"117899","DOI":"10.1016\/j.lfs.2020.117899","volume":"256","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Zarrabi A.; Hushmandi K.; Zarrin V.; Moghadam E.R.; Zabolian A.; Tavakol S.; Samarghandian S.; Najafi M.; PD-1\/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs. Life Sci 2020,256,117899","journal-title":"Life Sci"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"106807","DOI":"10.1016\/j.intimp.2020.106807","volume":"87","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Najafi M.; The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol 2020,87,106807","journal-title":"Int Immunopharmacol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/cancers13061240","volume":"13","author":"Crezee J.","year":"2021","unstructured":"Crezee J.; Franken N.A.P.; Oei A.L.; Hyperthermia-based anti-cancer treatments. Cancers (Basel) 2021,13(6),1240","journal-title":"Cancers (Basel)"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"119020","DOI":"10.1016\/j.lfs.2021.119020","volume":"269","author":"Mortezaee K.","year":"2021","unstructured":"Mortezaee K.; Narmani A.; Salehi M.; Bagheri H.; Farhood B.; Haghi-Aminjan H.; Najafi M.; Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy\/chemotherapy of cancer. Life Sci 2021,269,119020","journal-title":"Life Sci"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/2589977512666201228104528","volume":"13","author":"Nodooshan S.J.","year":"2021","unstructured":"Nodooshan S.J.; Amini P.; Ashrafizadeh M.; Tavakoli S.; Aryafar T.; Khalafi L.; Musa A.E.; Mahdavi S.R.; Najafi M.; Ahmadi A.; Farhood B.; Suberosin attenuates the proliferation of MCF-7 breast cancer cells in combination with radiotherapy or hyperthermia. Curr Drug Res Rev 2021,13(2),148-153","journal-title":"Curr Drug Res Rev"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/18755666MTA2dODEdz","volume":"21","author":"Amini P.","year":"2021","unstructured":"Amini P.; Nodooshan S.J.; Ashrafizadeh M.; Eftekhari S.M.; Aryafar T.; Khalafi L.; Musa A.E.; Mahdavi S.R.; Najafi M.; Farhood B.; Resveratrol induces apoptosis and attenuates proliferation of MCF-7 cells in combination with radiation and hyperthermia. Curr Mol Med 2021,21(2),142-150","journal-title":"Curr Mol Med"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00008469-200504000-00009","volume":"14","author":"Levi F.","year":"2005","unstructured":"Levi F.; Pasche C.; Lucchini F.; Ghidoni R.; Ferraroni M.; La Vecchia C.; Resveratrol and breast cancer risk. Eur J Cancer Prev 2005,14(2),139-142","journal-title":"Eur J Cancer Prev"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","volume":"4","author":"Howells L.M.","year":"2011","unstructured":"Howells L.M.; Berry D.P.; Elliott P.J.; Jacobson E.W.; Hoffmann E.; Hegarty B.; Brown K.; Steward W.P.; Gescher A.J.; Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 2011,4(9),1419-1425","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjh.12154","volume":"160","author":"Popat R.","year":"2013","unstructured":"Popat R.; Plesner T.; Davies F.; Cook G.; Cook M.; Elliott P.; Jacobson E.; Gumbleton T.; Oakervee H.; Cavenagh J.; A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br J Haematol 2013,160(5),714-717","journal-title":"Br J Haematol"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221014152759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210043\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221014152759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T20:34:45Z","timestamp":1728160485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210043\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":193,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666221014152759","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}